摘要
目的评价CT引导下经皮穿刺结核瘤内灌注给药治疗胸膜结核瘤的临床疗效。方法选择我院胸膜结核瘤68例,随机分为观察组(32例)和对照组(36例)。2组全身抗结核方案均为3HRZE(S)/6HR,观察组另给予CT引导下经皮穿刺结核瘤内灌注给药治疗。于第1月末,第2月末和疗程末观察2组瘤的大小和不良反应。结果观察组胸膜结核瘤消失率和明显缩小率均优于对照组(P<0.01);2组均无严重不良反应发生。结论CT引导下经皮穿刺瘤内灌注给药是治疗结核瘤有效和安全的方法,对促进结核瘤愈合有很好的作用,值得临床推广。
Objective To probe into a new treating method for pleura tubercle tumor and evaluate the clinical efficacy for pleura tubercle tumor with percutaneous pulmonary paracentesis and perfusing chemotherapy led by CT. Methods 68 patients with pleura tubercle tumor were randomly divided into two groups. 32 cases, as therapy group, were treated by percutaneous pulmonary paracentesis, while other 36 cases, as control group, were not. They were all treated with chemotheraphy, 3HRZE（S）/6HR. Results The curative rate and tumor obviously shrinking rate in the therapy group were both higher than in the control group （P〈0.01）. No obviously severe adverse effects were found in the two groups. Conclusion Percutaneous pulmonary paracentesis and perfusing chemotherapy led by CT is an effective method for treating pleura tubercle tumor. This method possesses the advantage of precise curative effect and leads to few complications. Therefore, it could be approached extensively in clinical practice.
出处
《医学新知》
CAS
2008年第4期206-207,210,共3页
New Medicine
关键词
结核瘤
胸膜
经皮穿刺
灌注
pleura tubercle tumor
percutaneous pulmonary paracentesis
perfusing chemotherapy
